Central Asian productivity forum in Tashkent strengthens regional economic cooperation

Kyrgyzstan, April 1 -- The first regional and international forum "Central Asia: From Productivity to Prosperity - Regional Dialogue" was held in Tashkent with the participation of key economic offici... Read More

MANIPUR HIGH COURT ISSUES ORDER ON BASTIMAYUM KARISHMA SHARMA V/S NINGTHOUKHONGJAM TOMBI RAY AND 8 ORS

IMPHAL, India, April 1 -- Manipur High Court issued the following order on Feb. 27: Due to paucity of time, hearing of these cases cannot be taken up today. On the joint request made by the learned... Read More

UAE Suspends All Visa Categories for Iranians Over Security Concerns

Afghanistan, April 1 -- The United Arab Emirates has suspended all visa categories for Iranian nationals, citing immediate travel and security measures amid heightened regional tensions. Flydubai sai... Read More

आज से 5-10 प्रतिशत तक महंगे होंगे एसी, टीवी और फ्रिज

प्रयागराज, अप्रैल 1 -- प्रयागराज, वरिष्ठ संवाददाता। गर्मी शुरू होते ही उपभोक्ताओं को झटका लगने वाला है। एक अप्रैल से एसी, फ्रिज, टीवी समेत कंप्रेसर आधारित इलेक्ट्रॉनिक उपकरणों की कीमतों में बढ़ोतरी ला... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More

• ««
• «
• 72778
• 72779
• 72780
• 72781
• 72782
• 72783
• 72784
• 72785
• 72786
• 72787
• »
• »»